# OnCo record nct06598527 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06598527/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06598527", "NCT06598527" ;
  schema:name "Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant The"@en ;
  schema:alternateName "SACTION2401"@en ;
  schema:description "A phase 3 trial of tislelizumab in lung cancer, run by Yang Hong, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06598527/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06598527> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "lung-deep-dive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/resectable-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/sbrt/> ;
  onco:drugs <https://onco.cc/drugs/tislelizumab/> .